Role of nanobiotechnology in cell-based nanomedicine: A concise review

Journal of Biomedical Nanotechnology

Volumn 3, Issue 3, 2007, Pages 235-244

  Emerich, Dwaine F ^a   Halberstadt, Craig ^b   Thanos, Christopher ^c  

^a In Cytu Inc   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Biomaterials; Cell transplantation; Imaging; Nanotechnology; Tissue engineering

Indexed keywords

BIOMATERIAL; CAMPTOTHECIN; CHITOSAN; DEXTRAN SULFATE; LIPOSOME; MACROGOL; NANOCAPSULE; NANOMATERIAL; NANOPARTICLE; NANOSPHERE; OLIGONUCLEOTIDE; PLASMID DNA; POLYAMIDOAMINE; POLYLACTIC ACID; POLYLYSINE; POLYMER; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; VIRUS VECTOR;

BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL TRANSPLANTATION; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; ENGRAFTMENT; GENE DELIVERY SYSTEM; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; IN VIVO STUDY; MOLECULAR MECHANICS; NANOANALYSIS; NANOBIOTECHNOLOGY; NANOMEDICINE; NANOSENSOR; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PHENOTYPE; REVIEW; SCREENING TEST; TISSUE ENGINEERING; TUMOR;

EID: 45849144414     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.036     Document Type: Review

References (85)

1. J. Alper, Nanotechnology "the small science" vs. cancer. Chemistry 23 (2005).
2. G. Maheshwari, G. Brown, D. A. Lauffenburg, A. Wells, and L. G. Griffith, Cell adhesion and motility depend on nanoscale RGD clustering. J. Cell Sci. 113, 1677 (2000).
3. E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Kneteman, J. R. Lakey, and A. M. Shapiro, Five-year follow-up after clinical islet transplantation. Diabetes 54, 2060 (2005).
4. B. S. Atiyeh, S. W. Gunn, and S. N. Hayak, State of the art in burn treatment. World J. Surg. 29, 131 (2005).
5. N. Parenteau, Skin: The first tissue-engineered products. Sci. Am. 280, 76 (1999).
6. J. Mansbridge, K. Liu, R. Patch, K. Symons, and E. Pinney, Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: Metabolic activity and therapeutic range. Tiss. Eng. 4, 403 (1998).
7. T. A. Mayhew, G. R. Williams, M. A. Senica, G. Kuniholm, and G. C. Du Moulin, Validation of a quality assurance program for autologous cultured chondrocyte implantation. Tiss. Eng. 4, 325 (1998).
8. A. F. Horwitz and T. Hunter, Cell adhesion: Integrating circuitry. Trends Cell Biol. 6, 460 (1996).
9. M. D. Pierschbacher, E. G. Hayman, and E. Ruoslahti, Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell 26, 259 (1981).
10. M. D. Pierschbacher, E. Ruoslahti, J. Sundelin, P. Lind, and P. A. Peterson, The cell attachment domain of fibronectin. Determination of the primary structure. J. Biol. Chem. 257, 9593 (1982).
11. J. A. Rowley, G. Madlambayan, and D. J. Mooney, Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20, 45 ( 1999).
12. A. Rezania and K. E. Healy, REZANIA A, Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol. Prog. 15, 19 (1999).
13. L. K. Hansen, D. J. Mooney, J. P. Vacanti, and D. E. Ingber, Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol. Biol. Cell 5, 967 (1994).
14. S. P. Massia and J. A. Hubbell, Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg- containing peptides to obtain well-defined cell-adhesive substrates. Anal. Biochem. 187, 292 ( 1990).
15. C. Halberstadt, C. Austin, and J. Rowley, A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tiss. Eng. 8, 309 (2002).
16. K. E. Drexler, Molecular engineering: An approach to the development of general capabilities for molecular manipulation. Proc. Natl. Acad. Sci. USA 78, 5275 (1981).
17. S. I. Stupp, Biomaterials for regenerative medicine. MRS Bulletin 30, 546 (2005).
18. K. Rajagopal and J. P. Schneider, Self-assembling peptides and proteins for nanotechnological applications. Curr. Opin. Struct. Biol. 14, 480 (2004).
19. T. Matsumoto, Y. C. Yung, C. Fischbach, H. J. Kong, R. Nakaoka, and D. J. Mooney, Mechanical strain regulates endothelial cell patterning in vitro. Tiss. Eng. 13, 207 (2007).
20. D. E. Ingber, L. Dike, and L. Hansen, Cellular tensegrity: Exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int. Rev. Cytol. 150, 173 (1994).
21. N. Wang, J. Butler, and D. Ingber, Mechanotransduction across the cell surface and through the cytoskeleton. Science 260, 1124 (1993).
22. C. T. Lim, E. H. Zhou, and S. T. Quek, Mechanical models for living cells - a review. J. Biomech. 36, 195 (2006).
23. D. E. Discher, P. Janmey, and Y. L. Wang, Tissue cells feel and respond to the stiffness of their substrate. Science 310, 1139 (2005).
24. D. M. Thompson and H. M. Buettner, Schwann cell response to micropatterned laminin surfaces. Tiss. Eng. 7, 247 (2001).
25. C. J. Lee, P. Huie, and T. Leng, Microcontact printing on human tissue for retinal cell transplantation. Arch. Ophthalmol. 120, 1714 ( 2002).
26. L. Rouxhet, F. Duhoux, O. Borecky, R. Legras, and Y J. Schneider, Adsorption of albumin, collagen, and fibronectin on the surface of poly(hydroxybutyrate-hydroxyvalerate) (PHB/HV) and of poly (epsilon-caprolactone) (PCL) films modified by an alkaline hydrolysis and of poly(ethylene terephtalate) (PET) track-etched membranes. J. Biomater. Sci. Polym. Ed. 9, 1279 (1998).
27. D. J. Irvine, A. V. Ruzette, A. M. Mayes, and L. G. Griffith, Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segregation of comb polymers in polylactide. Biomacromolecules 2, 545 (2001).
28. C. Du, F. Z. Cui, X. D. Zhu, and K. De Groot, Three-dimensional nano-HAp/ collagen matrix loading with osteogenic cells in organ culture. J. Biomed. Mater. Res. 44, 407 (1999).
29. R. Zhang and P. X. Ma, Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures. J. Biomed. Mater. Res. 52, 430 (2000).
30. V. N. Truskett and P. C. Watts, Trends in imprint lithography for biological applications. Trends Biotechnol. 24, 312 (2006).
31. P. Krsko and M. Libera, Biointeractive hydrogels. Mater. Today 8, 36 (2005).
32. W. He, K. E. Gonsalves, J. H. Pickett, and C. Halberstadt, Synthesis, characterization, and preliminary biological study of poly(3-(tert-butoxycarbonyl)-N-vinyl-2-pyrrolidone). Biomacromolecules 4, 75 (2003).
33. W. He, Halberstadt, and K. E. Gonslaves, Lithography application of a novel photoresist for patterning of cells. Biomaterials 25, 2055 (2004).
34. Y. Umar, M. Thiyagarajan, C. Halberstadt, and K. E. Gonsalves, Patterning of Cells on Bioresist for Tissue Engineering Applications. In Nanoscale Materials Science in Biology and Medicine, edited by C. Laurencian and E. A. Botchway, Materials Research Society, Warrendale, PA (2005), pp. 303-309.
35. A. F. Von Recum, A. F. Shannon, and C. E. Cannon, Surface roughness, porosity, and texture as modifiers of cellular adhesion. Tissue Eng. 2, 241 (1996).
36. Y. Umar, Nano/Micro Fabrication of Novel Polymers for Tissue Engineering Applications, Chemistry. Charlotte: University of North Carolina at Charlotte (2005).
37. R. Murugan and S. Ramakrishna, Nano-featured scaffolds for tissue engineering: A review of spinning methodologies. Tiss. Eng. 12, 435 (2006).
38. J. J. Stankus, J. Guan, K. Fujimoto, and W. R. Wagner, Microintegrating smooth muscle cells into a biodegradable, elastomeric fiber matrix. Biomaterials 27, 735 (2006).
39. P. X. Ma, Scaffolds for tissue fabrication. Mater. Today 30 ( 2004).
40. L. A. Smith and P. X. Ma, Nano-fibrous scaffolds for tissue engineering. Colloids Surf. B. Biointerfaces 39, 125 (2004).
41. S. H. Hsu, S. W. Whu, S. C. Hsieh, C. L. Tsai, D. C. Chen, and T. S. Tan, Evaluation of chitosan-alginate-hyaluronate complexes modified by an RGD-containing protein as tissue-engineering scaffolds for cartilage regeneration. Artif. Organs 28, 693 (2004).
42. P. K. Kreeger, J. W. Deck, T. K. Woodruff, and L. D. Shea, The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials 27, 714 (2006).
43. M. E. Oest, K. M. Dupont, H. j. Kong, D. J. Mooney, and R. E. Guldberg, Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J. Orthop. Res. 25, 941 (2007).
44. G. Orive, R. M. Hernandez, A. Rodriguez Gascon, R. Calafiore, T. M. Chang, P. deVos, G. Hortelano, D. Hunkeler, I. Lacik, and J. L. Pedraz, History, challenges, and perspectives of cell microen-capsulation. Trends Biotech. 22, 87 (2004).
45. J. L. Drury, T. Boontheekul, and D. J. Mooney, Cellular cross-talk of peptide modified hydrogels. J. Biomech. Eng. 127, 220 (2005).
46. A. D. Augst, H. J. Kong, and D. J. Mooney, Alginate hydrogels as biomaterials. Macromol. Biosci. 6, 623 (2006).
47. T. Matsumoto and D. J. Mooney, Cell instructive polymers. Adv. Biochem. Eng. Biotechnol. 102, 113 (2006).
48. H. J. Kong and D. J. Mooney, Macroenvironmental regulation of biomacromolecular therapies. Nat. Rev. Drug Discov. 6, 455 ( 2007).
49. A. Loebsack, K. Greene, S. Wyatt, C. Culberson, C. Austin, R. Beiler, W. Roland, P. Eiselt, J. Rowley, K. Burg, D. J. Mooney, W. Holder, and C. Halberstadt, In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J. Biomed. Mater. Res. 57, 575 ( 2001).
50. C. Halberstadt, C. Austin, J. Rowley, C. Culberson, A. Loebsack, S. Wyatt, S. Coleman, L. Blacksten, K. Burg, D. J. Mooney, and W. Holder, Jr., A hydrogel material for plastic and reconstructive applications injected into the subcutaneous space of a sheep. Tiss. Eng. 8, 309 (2002).
51. E. Hill, T. Boonthekul, and D. J. Mooney, Designing scaffolds to enhance transplanted myoblast survival and migration. Tiss. Eng. 12, 1295 (2006).
52. C. E. Thomas, A. Ehrhardt, and M. A. Kay, Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4, 346 ( 2003).
53. G. Romano, P. Michell, C. Pacilio, and A. Giordano, Latest developments in gene transfer technology: Achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18, 19 ( 2000).
54. S. Worgall, A realistic chance for gene therapy in the near future. Pediatr. Nephrol. 20, 118 (2005).
55. L. S. Young, P. F. Searle, D. Onion, and V. Mautner, Viral gene therapy strategies: From basic science to clinical application. J. Pathol. 208, 299 (2006).
56. E. Marshall, Gene therapy death prompts review of adenovirus vector. Science 286, 2244 (1999).
57. S. E. Raper, N. Chirmule, and F. S. Lee, Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol. Genet. Metab. 80, 148 ( 2003).
58. S. Hacein-Bey, C. Von Kalle, and M. Schmidt, LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415 (2003).
59. S. Hacein-Bey, C. Von Kalle, and M. Schmidt, A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255 (2003).
60. B. A. Khaw, J. Dasliva, I. Vural, J. Narula, and V. P. Torchilin, Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes. J. Control. Rel. 75, 199 (2001).
61. V. P. Torchilin, T. S. Levchenko, and R. Rammohan, Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome-DNA complexes. Proc. Natl. Acad. Sci. USA 100, 1972 (2003).
62. J. Park, J. Ries, and K. Gelse, Bone regeneration in critical size defects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes. Gene Ther. 10, 1089 (2003).
63. T. M. Allen, C. Hansen, and J. Rutledge, Liposomes with prolonged circulation times: Factors affecting uptake by reticuloendothelial and other tissues. Biochim. Biophys. Acta 981, 27 (1989).
64. T. M. Allen, C. Hansen, C. F. Martin, C. Redemann, and A. Yau-Young, Liposomes containing synthetic lipid derivative of poly (ethylene) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066, 29 (1991).
65. A. Gabizon, Selective tumor localization and improved therapeutic index of antracyclines encapsulated in long-circulating liposomes. Cancer Res. 52, 891 (1992).
66. O. M. Koo, I. Rubenstein, and H. Onyuksel, Camptothecin in sterically stabilized pbospholipid micelles: A novel nanomedicine. Nanomedicine 1, 77 (2005).
67. C. Perez, A. Sanchez, and D. Putnam, Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Control. Rel. 75, 211 (2001).
68. D. Putnam, A. N. Zelikin, V. A. Izumrudov, and R. Langer, Polyhistidine-PEG:DNA nanocomposites for gene delivery. Biomaterials 24, 4425 (2003).
69. H. Dai, X. Jiang, G. C. Chen, M. Torbenson, K. X. Leong, and H. Q. Mao, Chitosan-DNA nanoparticles delivered by intrabiliary infusion enhance liver-targeted gene delivery. Int. J. Nanomed. 1, 507 (2006).
70. H. L. Jiang, Y. K. Kim, R. Arote, J. W. Nah, M. H. Cho, Y. J. Choi, T. Akaike, and C. S. Cho, Chitosan-graft-polyethylenimine as a gene carrier. J. Cont. Rel. 117, 273 (2007).
71. R. Martien, B. loretz, M. Thaler, S. Maizoob, and A. Bernkop-Schnurch, Chitosan-thioglycolic acid conjugate: An alternative carrier for oral nonviral gene delivery. J. Biomed. Mater. Res. A. 82, 1 (2007).
72. A. V. Maksimenko, V. Mandrouguine, and M. B. Gottikh, Optimisation of dendrimer-mediated gene transfer by anionic oligomers. J. Gene Med. 5, 61 (2003).
73. N. Toub, J. R. Bertrand, C. Malvy, E. Fattal, and P. Couvreur, Antisense oligonucleotide, nanocapsules efficiently inhibit EWS-Flil expression in a Ewing's sarcoma model. Oligonucleotides 16, 158 (2006).
74. N. Toub, J. R. Bertrand, A. Tamaddon, H. Elhamess, H. Hillaireau, A. Maksimenko, J. Maccario, C. Malvy, E. Fattal, and P. Couvreur, Efficacy of siRNA nanocapsules targeted against the EWS-Flil oncogene in Ewing sarcoma. Pharm. Res. 23, 892 (2006).
75. A. P. Alivisato, W. Gu, and C. Larabell, Quantum dots as cellular probes. Ann. Rev. Biomed. Eng. 7, 55076 (2005).
76. R. Hardman, A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 114, 165 (2006).
77. H. A. Clark, R. Kopelman, R. Tjalkens, and M. A. Philbert, Optical nanosensors for chemical analysis inside single living cells. 2. Sensors for pH and calcium and the intracellular application of PEBBLE sensors. Anal. Chem. 71, 4837 (1999).
78. J. P. Sumner, J. W. Aylott, E. Monson, and R. Kopelman, A fluorescent PEBBLE nanosensor for intracellular free zinc. Analyst 127, 11 ( 2002).
79. M. N. Rhymer, A. M. Smith, G. Xiaohu, H. Mao, L. Yang, and S. Nie, Quantum dots and multifunctional nanoparticles: New contrast agents for tumor imaging. Nanomedicine 1, 209 (2006).
80. P. Wunderbaldninger, L. Josephson, and R. Weissleder, Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug. Chem. 13, 264 (2002).
81. J. W. Bulte, S. Zhang, and P. Van Gelderen, Neurotransplantation of magnetically labeled oligodendrocyte progenitors: Magnetic resonance tracking of cell migration and myelination. Proc. Natl. Acad. Sci. USA 96, 15256 (1999).
82. M. D. Dunning, A. Lakatos, and L. Loizou, Superparamagnetic iron oxide-labeled Schwann cells and olfactory ensheathing cells can be traced in vivo by magnetic resonance imaging and retain functional properties after transplantation into the CNS. J. Neurosci. 24, 9799 (2004).
83. D. L. Kraitchman, A. W. Heldman, and E. Atalar, In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107, 2290 (2003).
84. P. Jendelovam, V. Herynek, and L. Urdzikova, Magnetic resonance tracking of transplanted bone marrow and embryonic stem cells labeled by iron oxide nanoparticles in rat brain and spinal cord. J. Neurosci. Res. 76, 232 (2004).
85. A. C. Lepore, P. Walczak, M. S. Rao, I. Fischer, and J. W. Bulte, MR imaging of lineage-restricted neural precursors following transplantation into the adult spinal cord. Exp. Neurol. 201, 49 (2006).